FDA approval fueled a stock price surge for Geron Corporation.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA approval fueled a stock price surge for Geron Corporation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Geron Corporation
company
Related events
- Clene Inc. submitted an NDA to the FDA seeking accelerated approval while trading on the Nasdaq exchange.
- Tarsus Pharmaceuticals is seeking FDA approval in the US and is listed on the Nasdaq stock exchange.
- FDA granted accelerated approval for VOCERYQ, causing INOVIO stock to lead Nasdaq gainers.
- Benchmark and Jefferies reaffirmed buy ratings while the FDA cited toxicity findings for Bright Minds Biosciences Inc.